home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

FDA's New Enforcement of 21 CFR Part 11 - Webinar By GlobalCompliancePanel

 
  March 08, 2011  
     
 


GlobalCompliancePanel, Online Training Webinar
2011-05-04


verview: FDA's new Part 11 regulation takes quite some time, but inspectors go out and inspect computer systems and e-records for compliance with GMPs and most recent Part11 interpretations.

Just in 2007/2009, there have been about 30 Warning Letters related to Part 11 compliance, some with disastrous consequences for inspected companies. It seems that 'enforcement discretion' as stated in the 2003 guidance is not applied any more. FDA's computer expert John Murray recommended at a conference to follow 21 CFR Part 820 also for drug companies but industry needs more guidance and practical recommendations on how to respond to FDA's new enforcement practice.

Areas Covered in the Session:
  • FDA's current inspection and enforcement practices
  • FDA's new interpretation: learning from FDA guidance, and recent FDA conference presentations and discussions
  • Learning from FDA inspection reports
  • Part 11 and the new EU Annex 11: similarity and differences
  • Strategy for cost-effective implementation of the 'new' Part 11:A six step plan
  • Recommended changes to existing Part 11 programs to reduce costs
  • Justification and documentation for the FDA and your management
  • 15 Case studies from laboratories, offices and manufacturing with graphical workflow of records, step-by-step description, recommendations for individual Part 11 requirements with justifications and documentation for the FDA and your management.
  • How to prepare for Part 11 Inspections
Who Will Benefit:
  • IT managers and System Administrators
  • QA Managers and Personnel
  • Analysts and Lab Managers
  • Validation Groups
  • Software Developers
  • Validation Professionals
  • Training Departments
  • Documentation Department
  • Consultants
 
 
Organized by: GlobalCompliancePanel
Invited Speakers:
Ludwig Huber, Ph.D., is Director of Labcompliance and Chief Advisor for global FDA compliance at Agilent Technologies. He is the editor of Labcompliance, the global on-line resource for validation and compliance issues for laboratories. He is the author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems", Informa Healthcare.
 
Deadline for Abstracts: 2011-05-04
 
Registration: Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
E-mail: webinars@GlobalCompliancePanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.